You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Mental health, behavioural and neurodevelopmental conditions
  5. Psychosis and schizophrenia

Aripiprazole for the treatment of schizophrenia in people aged 15 to 17 years

  • Technology appraisal guidance
  • Reference number: TA213
  • Published:  26 January 2011
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Appendix A: decision paper presented to the Institute's Guidance Executive

Appendix A: decision paper presented to the Institute's Guidance Executive Appendix A: decision paper presented to the Institute's Guidance Executive
18 July 2011
(76.25 Kb 22 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 14 July 2011

Back to top